Cell Transplantation

Subscribe to Selected New Research on Cell Transplantation

1172 relevant articles (67 outcomes, 110 trials/studies) found for this Therapy

Description: Transference of cells within an individual, between individuals of the same species, or between individuals of different species.

Also Known As:

Transplantation, Cell; Cell Transplantations; Transplantations, Cell

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36585

Cell Transplantation: 1172

Stem Cell Transplantation: 4613

Islets of Langerhans Transplantation: 356

Experts

1.	Storb, Rainer: 34 articles (05/2008 - 07/2003)
2.	Sandmaier, Brenda M: 21 articles (02/2008 - 02/2003)
3.	Deeg, H Joachim: 16 articles (05/2008 - 05/2003)
4.	Maloney, David G: 16 articles (02/2008 - 02/2003)
5.	Appelbaum, Frederick R: 15 articles (06/2008 - 04/2002)
6.	Maris, Michael B: 14 articles (02/2008 - 09/2003)
7.	Forman, Stephen J: 13 articles (10/2008 - 09/2004)
8.	Martin, Paul J: 13 articles (05/2008 - 12/2003)
9.	Storer, Barry E: 12 articles (02/2008 - 02/2004)
10.	Blume, Karl G: 11 articles (08/2008 - 02/2003)

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/01/2007 - "RECENT FINDINGS: Early results with allogeneic hematopoietic cell transplantation after nonmyeloablative and reduced-intensity conditioning for patients with acute myeloid leukemia in first complete remission are encouraging, with 2-year survivals after hematopoietic cell transplantation ranging from 48 to 79% among studies" 03/01/2007 - "SUMMARY: Prospective studies are needed to define the place of allogeneic hematopoietic cell transplantation after nonmyeloablative or reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission, and to determine a role for consolidation chemotherapy before hematopoietic cell transplantation, if any." 03/01/2007 - "Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission." 03/01/2007 - "Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission." 06/01/2004 - "On the basis of transplantation data from the Japan Society for Hematopoietic Cell Transplantation, we retrospectively analyzed the impact of cytogenetics at diagnosis on the outcome of transplantation in 628 patients with acute myeloid leukemia who underwent autologous (n = 200), allogeneic related (n = 363), or allogenic unrelated (n = 65) stem cell transplantation (SCT) at first complete remission" Get all the results and reference details, order at left...
2.	Myocardial Infarction 08/30/2005 - "BACKGROUND: Cell transplantation offers the promise in the restoration of ventricular function after an extensive myocardial infarction, but the optimal cell type remains controversial" 09/01/2006 - "BACKGROUND: Recently, several preliminary reports have demonstrated that cell transplantation after acute myocardial infarction in humans is safe and leads to better preserved left ventricular function and improved myocardial perfusion and coronary flow reserve" 08/30/2005 - "CONCLUSIONS: Engrafted USSCs were detected in the infarct region 4 weeks after cell transplantation, and the implanted cells improved regional and global function of the porcine heart after a myocardial infarction" 06/01/2003 - "BACKGROUND: While neonatal cell transplantation improved function for acute myocardial infarction, long-term data on the effects of cell-transplant therapy using a more primitive cell on ventricular remodeling and function are needed" 01/01/2000 - "CONCLUSION: Autologous porcine heart cell transplantation improved regional perfusion and global ventricular function after a myocardial infarction." Get all the results and reference details, order at left...
3.	Graft vs Host Disease (Graft-Versus-Host Disease) 02/01/2005 - "The efficacy of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning depends on the balance between the desirable antineoplastic effects of donor cells weighed against the undesirable morbidity of graft-versus-host disease (GVHD)" 10/15/2006 - "The aim of this study was to understand the impact of chronic graft-versus-host disease (cGVHD) on the overall health status of hematopoietic cell transplantation (HCT) survivors" 10/15/2006 - "Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study." 08/01/2006 - "OBJECTIVE: To study the potential relationship between HHV-6 activation and acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic cell transplantation (HSCT)" 08/01/2005 - "Separate trials of the potential utility of these agents, particularly in the reduction of graft-versus-host disease, in the setting of hematopoietic cell transplantation have yielded encouraging results" Get all the results and reference details, order at left...
4.	Hematologic Neoplasms (Hematological Malignancy) 01/01/2006 - "Allogeneic hematopoietic cell transplantation (HCT) after myeloablative conditioning regimens has been an effective treatment for many patients with hematologic malignancies or inherited blood disorders" 01/01/2008 - "Recent development of hematopoietic cell transplantation (HCT) has greatly improved the quality of life in critical patients with hematological malignancies" 08/01/2006 - "The outcome of hematopoietic cell transplantation for hematologic malignancies may be improved by delivering targeted radiation to hematopoietic organs while relatively sparing nontarget organs" 05/01/2008 - "Allogeneic hematopoietic cell transplantation (HCT) is an increasingly widely used treatment modality in hematological malignancies" 05/01/2008 - "However, allogeneic hematopoietic cell transplantation (allo-HCT) still remains the sole curative therapy against chemotherapy-resistant hematological malignancies" Get all the results and reference details, order at left...
5.	Infection 12/01/2005 - "This overview summarizes recent data on emerging viruses after hematopoietic cell transplantation (HCT), including adenovirus, BK virus, human metapneumovirus (hMPV), and human herpesvirus (HHV) 6. The increased recognition of these infections is due to improved molecular detection methods, increased surveillance and more profound immunosuppression in the host" 09/01/2007 - "Our therapeutic design was based on data provided by both the use of Edmonton immunosuppressive steroid-free protocol in islets cell transplantation and the findings of international studies on the effects of this protocol in liver transplantation for patients with HCV infection" 12/01/2007 - "Organ/tissue/cell transplantation carries the risk of infection transfer from donor to recipient" 09/01/2007 - "The incidence of respiratory virus infection after hematopoietic cell transplantation (HCT) has probably been underestimated with conventional testing methods in symptomatic patients" 06/01/2007 - "Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation." Get all the results and reference details, order at left...
310 Diseases and 1172 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Etoposide (VP 16)
2.	Cyclophosphamide (Cytoxan)
3.	Busulfan (Busulfex)
4.	Cyclosporine (Ciclosporin)
5.	Retinaldehyde (Retinal)
6.	Calcineurin
7.	Tacrolimus (Prograf)
8.	Methotrexate (Mexate)
9.	Nerve Growth Factor (NGF)
10.	Sirolimus (Rapamycin)
172 Drugs and Important Bio-Agents and 230 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
2.	Transplants (Transplant)
3.	Drug Therapy (Chemotherapy)
4.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
5.	Stem Cell Transplantation
38 Therapies and Procedures and 192 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>